The effect of ranitidine on exocrine pancreatic secretion in the rat

Arch Int Pharmacodyn Ther. 1985 Mar;274(1):166-76.

Abstract

The effect of the H2-receptor antagonist ranitidine on pancreatic exocrine secretion was studied in the rat. In anaesthetized animals with acute fistulas pancreatic secretion was induced by central (2-deoxy-D-glucose, 2-DG) or peripheral (acetylcholine) cholinergic stimulants and by cholecystokinin and secretin. In some experiments cimetidine was used as a reference compound. Ranitidine (20 mg X kg-1 intraperitoneally) did not change neither basal secretion nor the response to the combined hormonal stimulation. On the contrary, it significantly increased 2-DG and acetylcholine-stimulated secretion, whereas cimetidine (100 mg X kg-1 intraperitoneally) inhibited the pancreatic response to 2-DG. The different behaviour of the two H2-antagonists suggests that the effect of ranitidine is independent of the H2-receptor blockade and most probably connected with the cholinergic-like action of the drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Cholecystokinin / pharmacology
  • Cimetidine / pharmacology
  • Deoxyglucose / pharmacology
  • Injections, Intraperitoneal
  • Male
  • Pancreas / metabolism*
  • Proteins / metabolism
  • Ranitidine / administration & dosage
  • Ranitidine / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Sodium / metabolism
  • Stimulation, Chemical

Substances

  • Proteins
  • Cimetidine
  • Ranitidine
  • Cholecystokinin
  • Deoxyglucose
  • Sodium
  • Acetylcholine